Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice: barriers to and strategies for optimal implementation
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice: barriers to and strategies for optimal implementation
Authors
Keywords
-
Journal
EUROPACE
Volume 17, Issue 7, Pages 1007-1017
Publisher
Oxford University Press (OUP)
Online
2015-06-27
DOI
10.1093/europace/euv068
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- All-Cause and Bleeding-Related Health Care Costs in Warfarin-Treated Patients with Atrial Fibrillation
- (2016) Sameer R. Ghate et al. JOURNAL OF MANAGED CARE PHARMACY
- Cost Implications of Formulary Decisions on Oral Anticoagulants in Nonvalvular Atrial Fibrillation
- (2016) Joseph Biskupiak et al. JOURNAL OF MANAGED CARE PHARMACY
- Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
- (2014) Emily C. O’Brien et al. AMERICAN HEART JOURNAL
- Variations in Cause and Management of Atrial Fibrillation in a Prospective Registry of 15 400 Emergency Department Patients in 46 Countries
- (2014) Jonas Oldgren et al. CIRCULATION
- Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naive atrial fibrillation patients: Danish nationwide descriptive data 2011-2013
- (2014) J. B. Olesen et al. EUROPACE
- Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation
- (2014) Riccardo Cappato et al. EUROPEAN HEART JOURNAL
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2014) Craig T. January et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: A global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation
- (2013) Menno V. Huisman et al. AMERICAN HEART JOURNAL
- Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation
- (2013) James V. Freeman et al. ANNALS OF INTERNAL MEDICINE
- Risks and Benefits of Anticoagulation in Atrial Fibrillation
- (2013) Michael W. Cullen et al.
- Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin for Stroke Prevention in Non-Valvular Atrial Fibrillation: A Cost-Effectiveness Analysis
- (2013) Carla Rognoni et al. CLINICAL DRUG INVESTIGATION
- Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey
- (2013) G. Y. H. Lip et al. EUROPACE
- European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
- (2013) Hein Heidbuchel et al. EUROPACE
- Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events—European Registry in Atrial Fibrillation (PREFER in AF)
- (2013) Paulus Kirchhof et al. EUROPACE
- Improving cardiovascular disease management in Australia: NPS MedicineWise
- (2013) Svetla V Gadzhanova et al. MEDICAL JOURNAL OF AUSTRALIA
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-Effectiveness of Rivaroxaban Versus Warfarin for Stroke Prevention in Atrial Fibrillation in the Belgian Healthcare Setting
- (2013) Joris Kleintjens et al. PHARMACOECONOMICS
- Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry
- (2013) Ajay K. Kakkar et al. PLoS One
- Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation
- (2013) Amanda R. Harrington et al. STROKE
- Patient outcomes using the European label for dabigatran
- (2013) Andreas Clemens et al. THROMBOSIS AND HAEMOSTASIS
- Cost–Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation
- (2012) Soyon Lee et al. AMERICAN JOURNAL OF CARDIOLOGY
- Frequency, Patient Characteristics, Treatment Strategies, and Resource Usage of Atrial Fibrillation (from the Italian Survey of Atrial Fibrillation Management [ISAF] Study)
- (2012) Massimo Zoni-Berisso et al. AMERICAN JOURNAL OF CARDIOLOGY
- Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control
- (2012) Allan C. Skanes et al. CANADIAN JOURNAL OF CARDIOLOGY
- The Global Burden of Atrial Fibrillation and Stroke
- (2012) Gregory Y.H. Lip et al. CHEST
- Antithrombotic Therapy for Atrial Fibrillation
- (2012) John J. You et al. CHEST
- Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation
- (2012) Masatsugu Hori et al. CIRCULATION JOURNAL
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
- (2012) et al. EUROPACE
- Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation
- (2012) Anuraag R Kansal et al. HEART
- Atrial fibrillation management, outcomes and predictors of stable disease in daily practice: Prospective non-interventional study
- (2012) Ralph F. Bosch et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Stroke Care in Central Eastern Europe: Current Problems and Call for Action
- (2012) Laura Lenti et al. International Journal of Stroke
- Prognosis in Patients with Atrial Fibrillation and CHA2DS2-VASc Score = 0 in a Community-Based Cohort Study
- (2012) SOPHIE TAILLANDIER et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF
- (2012) Graeme J Hankey et al. LANCET NEUROLOGY
- Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial
- (2012) J Donald Easton et al. LANCET NEUROLOGY
- Is Dabigatran Cost Effective Compared With Warfarin for Stroke Prevention in Atrial Fibrillation?
- (2012) Amelia K. Adcock et al. NEUROLOGIST
- Perceived barriers to guideline adherence: A survey among general practitioners
- (2011) Marjolein Lugtenberg et al. BMC Family Practice
- Cost-Effectiveness of Dabigatran for Stroke Prophylaxis in Atrial Fibrillation
- (2011) Shimoli V. Shah et al. CIRCULATION
- Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry
- (2011) Thomas Meinertz et al. Clinical Research in Cardiology
- Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections
- (2011) Hrafnhildur Stefansdottir et al. EUROPACE
- Apixaban in Patients with Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: A Canadian payer perspective
- (2011) Anuraag Kansal et al. THROMBOSIS AND HAEMOSTASIS
- Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk?
- (2010) Peter J. Zimetbaum et al. AMERICAN JOURNAL OF MEDICINE
- Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2008)
- (2010) JCS Joint Working Group CIRCULATION JOURNAL
- The likelihood of decreasing strokes in atrial fibrillation patients by strict application of guidelines
- (2010) R. Pisters et al. EUROPACE
- The Stroke Practice Improvement Network: A Quasiexperimental Trial of a Multifaceted Intervention to Improve Quality
- (2010) Judith A. Hinchey et al. Journal of Stroke & Cerebrovascular Diseases
- Direct and indirect costs of management of long-term warfarin therapy in Canada
- (2010) S. SCHULMAN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial
- (2010) Hans-Christoph Diener et al. LANCET NEUROLOGY
- Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
- (2010) Karen L. Furie et al. STROKE
- Heart Disease and Stroke Statistics—2010 Update
- (2009) et al. CIRCULATION
- The German Competence Network on Atrial Fibrillation (AFNET)
- (2009) Günter Breithardt et al. HERZ
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
- (2008) CEREBROVASCULAR DISEASES
- Get With the Guidelines–Stroke Is Associated With Sustained Improvement in Care for Patients Hospitalized With Acute Stroke or Transient Ischemic Attack
- (2008) Lee H. Schwamm et al. CIRCULATION
- Epidemiology, Risk Factors for Stroke, and Management of Atrial Fibrillation in China
- (2008) Dayi Hu et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Status of the Epidemiology of Atrial Fibrillation
- (2007) William B. Kannel et al. MEDICAL CLINICS OF NORTH AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started